lactobacillus bulgaricus Report issue

Cell therapy Experimental
AACT

Active Ingredient History

NOW
  • Now
Lactobacillus bulgaricus is one of over 200 published species in the Lactobacillus genome complex (LGC) and is the main bacterium used for the production of yogurt. It also plays a crucial role in the ripening of some cheeses, as well as in other processes involving naturally fermented products. It is defined as homofermentive lactic acid bacteria due to lactic acid being the single end product of its carbohydrate digestion. It is also considered a probiotic.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

lactobacillus bulgaricus

Organizations (14)

Research & Development (14)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (11)

Approved Indications (1)


 

Gastrointestinal Microbiome

Experimental Indications - Clinical Trial Phases 1-4 (10)


 

Breast Neoplasms (Phase 2/Phase 3)

Celiac Disease (Phase 4)

Diabetes Mellitus (Phase 2)

Esophageal and Gastric Varices (Phase 3)

Fibrosis (Phase 3)

Hepatic Encephalopathy (Phase 4)

HIV (Phase 1/Phase 2)

Inflammation (Phase 2)

Kidney Failure, Chronic (Phase 2)

Sjogren's Syndrome (Phase 1/Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial Organizations: 14

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue